These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2800494)

  • 1. [Laboratory diagnosis of pancreatitis and pancreatic cancer].
    Degtiareva II; Gaĭsenko AV; Putseva NM
    Vrach Delo; 1989 Jul; (7):42-4. PubMed ID: 2800494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CA 19-9 in serum and pancreatic juice: its role in the differential diagnosis of resectable pancreatic cancer from chronic pancreatitis.
    Malesci A; Evangelista A; Mariani A; Bersani M; Bonato C; Basilico M; Montorsi M; Beretta E
    Int J Pancreatol; 1988; 3 Suppl 1():S119-23. PubMed ID: 3209865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CA 19-9 assay in differential diagnosis of pancreatic carcinoma from inflammatory pancreatic diseases.
    Piantino P; Andriulli A; Gindro T; Pecchio F; Masoero G; Cavallini G; Naccarato R; Dobrilla G
    Am J Gastroenterol; 1986 Jun; 81(6):436-9. PubMed ID: 3458359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic importance of the tumor marker CA 19-9 in pancreatic cancer].
    Safi F; Büchler M; Schenkluhn B; Beger HG
    Dtsch Med Wochenschr; 1984 Dec; 109(49):1869-73. PubMed ID: 6209082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of carbohydrate antigen (CA) 19-9 levels in pure pancreatic juice of patients with pancreatic cancer.
    Nishida K; Tasaki N; Miyagawa H; Yoshikawa T; Kondo M
    Am J Gastroenterol; 1988 Feb; 83(2):126-9. PubMed ID: 3422536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The significance of trypsin, amylase and lipase activities in the blood serum for the differential,diagnosis of chronic pancreatitis and other diseases of the abdominal organs].
    Geller LI; Pashko MM
    Vrach Delo; 1990 Mar; (3):86-8. PubMed ID: 1695041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum immunoreactive trypsin in chronic pancreatitis patients].
    Tŭrkolev N; Brailski Kh; Mendizova A
    Vutr Boles; 1985; 24(1):36-40. PubMed ID: 4024607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum CA 242 in pancreatic cancer. Comparison with CA 19-9 and CEA.
    Pezzilli R; Billi P; Plate L; Laudadio MA; Sprovieri G
    Ital J Gastroenterol; 1995; 27(6):296-9. PubMed ID: 8562994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer.
    Ozkan H; Kaya M; Cengiz A
    Hepatogastroenterology; 2003; 50(53):1669-74. PubMed ID: 14571813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoamylases in pancreatic carcinoma and chronic relapsing pancreatitis.
    Skude G; Ihse I
    Scand J Gastroenterol; 1977; 12(1):53-7. PubMed ID: 834969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radioimmunoassay in the evaluation of pancreas function in chronic pancreatitis].
    Zubovskiĭ GA; Vasil'chenko SA
    Med Radiol (Mosk); 1983 Dec; 28(12):3-8. PubMed ID: 6358762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of the carbohydrate antigen CA-50 in pancreatic disease.
    Blind PJ; Dahlgren ST
    Acta Chir Scand; 1987 Jan; 153(1):45-9. PubMed ID: 3472420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differential diagnostic evaluation of chronic pancreatitis in relation to pancreatic cancer based on clinical, laboratory chemical and diagnostic parameters. Studies of 174 patients in 10 years].
    Gronen G; Dombrowski H; Adler G; Lorenz-Meyer H
    Z Gastroenterol; 1986 Aug; 24(8):416-25. PubMed ID: 3532595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Accuracy of imaging techniques and tumor markers in the diagnosis of pancreatic cancer].
    Clavé P; Boadas J; González-Carro P; Mora J; Pérez C; Martínez A; Roca M; Lluís F; Farré A
    Gastroenterol Hepatol; 1999; 22(7):335-41. PubMed ID: 10535205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinico-morphological correlations of chronic pseudotumorous pancreatitis and cancer of the pancreas].
    Loginov AS; Sadokov VM; Chukunova BZ
    Klin Med (Mosk); 1992; 70(5-6):24-7. PubMed ID: 1434392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic significance of pancreatic antigen determination].
    Velbri S; Männiste J
    Z Gesamte Inn Med; 1980 Sep; 35(17):684-8. PubMed ID: 6162288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CA 50 compared with CA 19-9 as a serum tumour marker for pancreatic carcinoma.
    Pasquali C; Sperti C; D'Andrea AA; Costantino V; Filipponi C; Pedrazzoli S
    Ital J Gastroenterol; 1994 May; 26(4):169-73. PubMed ID: 7949259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum tissue polypeptide antigen in the differential diagnosis of chronic pancreatitis and exocrine pancreatic tumors. Preliminary results].
    Ruibal A; Encabo G
    Rev Esp Oncol; 1983; 30(3):313-6. PubMed ID: 6571374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum markers and clinical data in diagnosing pancreatic cancer: a contrastive approach.
    Fabris C; Del Favero G; Basso D; Piccoli A; Meggiato T; Angonese C; Plebani M; Leandro G; Burlina A; Naccarato R
    Am J Gastroenterol; 1988 May; 83(5):549-53. PubMed ID: 3163228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value of serum TAG-72 as a tumor marker for pancreatic carcinoma. Comparison with CA 19-9.
    Pasquali C; Sperti C; D'Andrea AA; Costantino V; Filipponi C; Pedrazzoli S
    Int J Pancreatol; 1994 Jun; 15(3):171-7. PubMed ID: 7930777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.